This event is a one-of-a-kind, interactive forum where top diligence experts will discuss best practices and strategies for executing a proper IP due diligence analysis, both for your own portfolio, and that of potential targets.
Over the past few years, with many blockbuster drug patents expiring, R&D pipelines drying up, and the evolving challenges for patenting life-sciences inventions, many have coined the current landscape as “anti-patent.” As a result, there has been steady increase in companies looking to collaborate and do deals to protect their assets, maintain market share, and maximize the life of their patent portfolios.
In response to challenging patent landscape surrounding the pharmaceutical, biotechnology, and medical device industries, ACI has pioneered a conference tailored specifically to professionals involved with intellectual property due diligence for life sciences inventions. Our Life Sciences IP Due Diligence Summit is a one-of-a-kind gathering place for key stakeholders to learn the best strategies and tips to map out and conduct a successful and cost-effective due diligence analysis.
Agenda and speakers list will be available soon. Stay up-to-date by signing up for email updates.
Don’t miss this opportunity to benchmark your IP diligence strategies with top industry representatives. Register now and enjoy early bird savings!
Hear what past participants have to say about this one-of-a-kind event:
“Unique high level sessions, good mix of in-house and outside counsel”
“Hearing from professionals involved in due diligence on a daily basis was very informative.”
“Great panels, lots of diversity of practice, and lots of seasoned practitioners”
“The design of the event brought us all together along with room intimacy”
“High quality and level of conversations”
“Awesome- Interactive and thorough information”
“Good focused discussions covering all aspects”